Tissue Regenix Group plc Profit Margin

The latest profit margin for TSSNF is -5.33% as of June 2024. That compares with -39.98% in the prior-year period — up 86.7% year over year. That is below the sector sector average of 22.52%. Investors often review this figure alongside Tissue Regenix Group plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, TSSNF's profit margin moved from -39.98% to -5.33% — a 86.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tissue Regenix Group plc's valuation or profitability profile.

Against its sector companies, TSSNF currently prints -5.33% for profit margin, while the sector average sits near 22.52%. That is roughly 123.7% below the sector mean. Large gaps often invite a closer look at Tissue Regenix Group plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Tissue Regenix Group plc converts resources into returns. At -5.33%, TSSNF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -39.98% in the prior-year period — up 86.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TSSNF's profit margin (-5.33%), review year-over-year change from -39.98%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.